AT
AZN icon

Arlington Trust’s AstraZeneca AZN Stock Holding History

Arlington Trust’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.4K Buy
+97
New +$18.2K ﹤0.01% 399
2025
Q4 		– Sell
-211
Closed -$32.4K – 450
2025
Q3 		$32.4K Hold
211
– – 0.01% 402
2025
Q2 		$29.5K Hold
211
– – 0.01% 404
2025
Q1 		$31K Hold
211
– – 0.01% 411
2024
Q4 		$27.6K Hold
211
– – 0.01% 398
2024
Q3 		$32.9K Hold
211
– – 0.01% 367
2024
Q2 		$32.9K Hold
211
– – 0.01% 368
2024
Q1 		$28.6K Sell
211
-61
-22% -$8.08K 0.01% 311
2023
Q4 		$36.6K Buy
+272
New +$35.4K 0.01% 307

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

Arlington Trust's AZN Position: Q2 2026 in Review

Arlington Trust opened a new position in AstraZeneca (AZN) in Q2 2026: 97 shares worth $18.4K. The stake represents ﹤0.01% of the portfolio and ranks #399 among its holdings. This is a return to the name: Arlington Trust previously reported a position in AZN as recently as Q3 2025.

Arlington Trust first reported a position in AZN in Q4 2023 and has held it in 9 quarters since. The position peaked at $36.6K in Q4 2023. 430 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Arlington Trust held 97 shares of AstraZeneca worth $18.4K as of Q2 2026.
  • AstraZeneca was a new Arlington Trust position in Q2 2026.
  • AstraZeneca made up ﹤0.01% of Arlington Trust's portfolio in Q2 2026, its #399 holding.
  • Arlington Trust first reported a position in AstraZeneca in Q4 2023 and has held it in 9 quarters since.
  • Arlington Trust's AstraZeneca position peaked at $36.6K in Q4 2023.
  • 430 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.